GA00 - Vulvitis: Complete Clinical Coding Guide

1. Introduction

Vulvitis represents one of the most frequent inflammatory processes of the female genital tract, characterized by inflammation of the vulva, which comprises the external female genital structures including the labia majora, labia minora, clitoris, and vaginal vestibule. This condition can affect women of all ages, from childhood to advanced age, presenting as a significant diagnostic and therapeutic challenge in gynecological practice.

The clinical importance of vulvitis transcends immediate physical discomfort, and can profoundly impact patients' quality of life, interfering with daily activities, sexual function, psychological well-being, and interpersonal relationships. The condition can manifest in acute or chronic form, with varied etiologies that include infections, allergic reactions, chemical irritants, dermatological conditions, and hormonal factors.

From an epidemiological perspective, vulvitis constitutes a common reason for gynecological consultation, representing a significant proportion of specialized outpatient visits. The exact prevalence varies according to the population studied and diagnostic criteria used, but studies indicate that a considerable proportion of women will experience some episode of vulvitis during their lifetime.

Correct coding of vulvitis using the GA00 code from ICD-11 is fundamental for multiple aspects of health care. First, it allows for appropriate epidemiological recording, facilitating prevalence and incidence studies. Additionally, it ensures appropriate reimbursement by health systems, justifies the need for specific treatments, and enables longitudinal follow-up of patients. Accurate documentation also contributes to clinical research, development of therapeutic protocols, and targeted public health policies.

2. Correct ICD-11 Code

The code GA00 in the International Classification of Diseases, 11th Revision (ICD-11), is designated specifically for Vulvitis, representing inflammatory processes affecting the vulva regardless of the specific etiology.

This code belongs to the superior category of Inflammatory disorders of the female genital tract, positioning itself as the first code in this important category of gynecological conditions. The hierarchical structure of ICD-11 organizes diseases in a logical manner, facilitating navigation and selection of the appropriate code.

The designation GA00 encompasses all forms of vulvitis, whether infectious (bacterial, fungal, viral, or parasitic), non-infectious (irritative, allergic, dermatological), acute or chronic. This breadth allows the code to be applied in various clinical contexts, as long as the inflammatory process is primarily localized to the vulva.

It is important to note that code GA00 is sufficiently specific to identify the anatomical location of the inflammatory process (vulva), differentiating it from other conditions of the female genital tract, but also sufficiently comprehensive to encompass the multiple possible etiologies. In situations where the specific cause is known and relevant to clinical management, additional codes may be used in conjunction to detail the etiology, such as codes for specific infectious agents.

The implementation of ICD-11 brought greater clarity in the classification of female genital inflammatory disorders, with more specific codes for each anatomical location, facilitating precise coding and reducing ambiguities that existed in previous versions of the classification.

3. When to Use This Code

The code GA00 should be used in specific clinical situations where there is clear evidence of vulvar inflammatory process. Below, we present detailed practical scenarios:

Scenario 1: Acute Infectious Vulvitis A patient presents with recent onset (less than one week) characterized by intense vulvar erythema, edema of the labia majora and minora, severe pruritus, and dysuria. On physical examination, diffuse hyperemia of the vulva is observed, presence of whitish discharge adhered to vulvar structures, and increased sensitivity to palpation. The patient reports recent antibiotic use for urinary tract infection. Microscopic examination reveals presence of hyphae, suggesting vulvar candidiasis. In this case, GA00 is appropriate and may be complemented with a specific code for the etiologic agent.

Scenario 2: Allergic Contact Vulvitis Patient develops vulvitis after introduction of a new intimate hygiene product. Presents with bilateral vulvar erythema, intense pruritus, burning sensation, and small vesicles in the region of the labia minora. There is no associated vaginal discharge. Detailed history reveals use of perfumed soap over the last three days. Physical examination confirms alterations limited to the vulva, without vaginal involvement. Discontinuation of the irritant product results in progressive improvement. The code GA00 is appropriate for this presentation of irritative/allergic vulvitis.

Scenario 3: Chronic Recurrent Vulvitis Woman with history of multiple episodes of vulvitis over the last six months, with periods of exacerbation and partial remission. Presents with persistent vulvar erythema, thickening of vulvar skin (lichenification) secondary to chronic pruritus and repeated scratching. Previous cultures were negative for common infectious agents. The presentation suggests chronic vulvitis of multifactorial etiology, possibly related to cumulative irritative factors and alterations in the skin barrier. GA00 is the appropriate code to document this chronic condition.

Scenario 4: Pediatric Vulvitis Prepubertal child presents with vulvar erythema, pruritus, and local discomfort. On examination, hyperemia of the vulva is observed without significant vaginal involvement. The mother reports that the child has a habit of remaining in wet swimwear for prolonged periods. There are no signs of abuse or foreign body. This is irritative vulvitis common in the pediatric age group, appropriately coded as GA00.

Scenario 5: Non-Atrophic Postmenopausal Vulvitis Postmenopausal patient develops vulvitis secondary to prolonged use of daily absorbent pads. Presents with localized vulvar erythema, skin maceration, and discomfort. Examination does not reveal significant atrophy of vulvar epithelium, and the patient does not present other symptoms of genitourinary syndrome of menopause. The process is primarily irritative/inflammatory, justifying the use of GA00.

Scenario 6: Vulvitis Secondary to Incontinence Woman with urinary incontinence develops vulvitis secondary to chronic exposure to moisture and urine. Presents with diffuse vulvar erythema, skin maceration, local discomfort, and characteristic odor. The inflammatory process is clearly localized to the vulva, related to the chemical irritant (urine) and constant moisture. GA00 is appropriate and may be complemented with a code for the underlying incontinence.

4. When NOT to Use This Code

It is fundamental to recognize situations where code GA00 should not be applied, avoiding coding errors that may compromise medical records and reimbursements:

Senile (Atrophic) Vaginitis: When the patient presents with vulvovaginal atrophy related to postmenopausal estrogen deficiency, with epithelial thinning, loss of vaginal rugae, mucosal pallor, and symptoms such as dryness, dyspareunia, and postcoital bleeding, the appropriate code is 1876048433 (Senile/atrophic vaginitis), not GA00. The fundamental distinction is that atrophic vaginitis represents a hormonal degenerative process, not primarily inflammatory.

Primary Vaginitis: When the inflammatory process is located predominantly in the vagina, with abundant vaginal discharge, alterations in vaginal pH, and inflammatory signs on speculum examination, the correct code is GA02 (Vaginitis), even if there is some secondary vulvar involvement. The primary location of the process determines the code.

Specific Bartholin's Gland Diseases: Abscesses, cysts, or bartholinitis (specific inflammation of Bartholin's gland) should be coded as GA03 (Bartholin's gland diseases), not as generalized vulvitis. Anatomical specificity takes precedence.

Endometritis or Myometritis: Inflammatory processes of the uterus, even when accompanied by pelvic symptoms that may include reflex vulvar discomfort, should be coded as GA01 (Inflammatory disorders of the uterus, except cervix).

Specific Vulvar Dermatoses: Conditions such as lichen sclerosus, lichen planus, or vulvar psoriasis have specific codes in other ICD-11 categories, generally in dermatological sections. Although they may cause vulvar inflammation, the specific nature of these conditions requires appropriate coding.

Vulvar Neoplasms: Premalignant or malignant lesions of the vulva should not be coded as vulvitis, even if they present with secondary inflammatory component. Specific oncological codes are necessary.

5. Coding Step by Step

Step 1: Assess Diagnostic Criteria

The diagnosis of vulvitis is based primarily on detailed clinical evaluation. Begin with a complete history investigating: onset of symptoms, duration, characteristics of discomfort (pruritus, burning, pain), triggering or aggravating factors, use of hygiene products, medications, sexual activity, history of similar previous conditions, and treatments already performed.

Physical examination should include careful inspection of the entire vulva under adequate lighting, observing erythema, edema, presence of lesions (vesicles, ulcers, fissures), color changes, skin thickening, or lichenification. Also assess the presence of secretions, their appearance, quantity, and location. Gentle palpation allows evaluation of sensitivity and identification of masses or induration.

Complementary tests may include: direct microscopy of secretions, culture of vulvar or vaginal secretions when appropriate, pH testing, and in selected cases, biopsy of atypical lesions. Contact testing may be considered when allergic contact vulvitis is suspected.

Step 2: Check Specifiers

Determine the specific characteristics of vulvitis present: acute (recent onset, intense symptoms) versus chronic (duration exceeding three months, fluctuating course). Assess severity: mild (minimal symptoms, do not interfere with daily activities), moderate (significant discomfort, some functional limitation), or severe (intense symptoms, significant impact on quality of life).

Identify the etiology when possible: infectious (specify agent when known), irritative, allergic, traumatic, or idiopathic. Document the extent of involvement: localized (specific areas of the vulva) or diffuse (entire vulvar region).

Step 3: Differentiate from Other Codes

GA01 (Inflammatory disorders of the uterus, except cervix): The fundamental difference lies in anatomical location. GA01 refers to inflammatory processes of the uterine body (endometrium, myometrium), typically manifesting with pelvic pain, abnormal uterine bleeding, fever, and uterine tenderness on bimanual palpation. There is no primary vulvar involvement.

GA02 (Vaginitis): The critical distinction is the predominant location of the inflammatory process. Vaginitis presents vaginal discharge as the cardinal symptom, alterations in vaginal pH, inflammatory signs on vaginal mucosa on speculum examination. Although secondary vulvar involvement may occur (vulvovaginitis), the primary process is vaginal. In GA00, the vulva is the primary and predominant site.

GA03 (Bartholin gland diseases): This code is specific for pathologies of the Bartholin glands, located in the posterolateral portion of the vaginal vestibule. They manifest as a localized, unilateral mass, painful (abscess) or painless (cyst), with localized inflammatory signs. GA00 represents diffuse or multifocal inflammation of the vulva, not limited to the Bartholin glands.

Step 4: Required Documentation

Adequate documentation should include:

Mandatory checklist:

Date of symptom onset
Detailed description of symptoms (pruritus, pain, burning, discomfort)
Findings of vulvar physical examination (location, extent, characteristics of lesions)
Triggering or associated factors identified
Results of complementary tests performed
Differential diagnoses considered
Justification for the selected GA00 code
Etiology when identified (with additional code if appropriate)
Therapeutic plan instituted

The record should be sufficiently detailed to allow another professional to clearly understand the clinical presentation and coding justification, as well as to enable proper audit.

6. Complete Practical Example

Clinical Case

A 34-year-old nulliparous patient presents to gynecological consultation with a complaint of "itching and burning in the external genital region" for approximately ten days. She reports that symptoms began after returning from a beach trip, where she remained in wet swimwear for prolonged periods during five consecutive days.

The patient describes intense vulvar pruritus, worse at night, burning sensation upon urination (external dysuria), and discomfort when wearing tight pants. She denies vaginal discharge, abnormal odor, fever, or systemic symptoms. She has not had recent sexual relations. She reports having used antibacterial intimate soap daily during the trip, a product she did not normally use. She attempted self-medication with regular moisturizing cream without improvement.

Gynecological history: regular menstrual cycles, last menstruation twelve days ago, no history of previous genital infections. She denies known drug allergies. She does not use regular medications.

On physical examination: patient in good general condition, afebrile. Vulvar examination reveals diffuse erythema involving the labia majora and minora bilaterally, mild edema of the labia minora, without ulcerated or vesicular lesions. Superficial linear excoriations secondary to scratching are observed. No palpable masses or inguinal lymphadenopathy. Speculum examination: vaginal mucosa with normal appearance, without abnormal discharge, cervix with usual appearance. Bimanual examination: uterus of normal size, mobile, painless, adnexa not palpable.

Complementary tests performed: vaginal pH 4.2 (normal), direct microscopy of vaginal secretion: normal epithelial cells, predominant lactobacilli, absence of hyphae, trichomonads, or clue cells. Amine test negative.

Step-by-Step Coding

Criteria Analysis:

The clinical presentation clearly characterizes an inflammatory process localized primarily to the vulva. The cardinal symptoms (pruritus, burning, external dysuria) associated with physical examination findings (diffuse vulvar erythema, edema) confirm the diagnosis of vulvitis.

The absence of significant vaginal discharge, normal vaginal pH, and microscopy without alterations rule out vaginitis as the primary diagnosis. The involvement is exclusively vulvar, without signs of inflammatory processes in other structures of the genital tract.

The history of exposure to irritative factors (prolonged moisture, use of unfamiliar soap) suggests irritative/allergic etiology, characterizing non-infectious vulvitis.

Code Selected: GA00 - Vulvitis

Complete Justification:

Anatomical location: The inflammatory process is clearly localized to the vulva (labia majora and minora), without vaginal, uterine, or specific glandular involvement.
Nature of the process: This is an acute inflammatory process (ten days of evolution) with clinical signs typical of vulvitis.
Exclusion of alternative diagnoses:
- Not vaginitis (GA02): absence of vaginal discharge, normal pH, vaginal examination without alterations
- Not Bartholin disease (GA03): no localized mass or specific glandular involvement
- Not atrophic vaginitis: patient of reproductive age with normal ovarian function
Diagnostic criteria satisfied: Characteristic symptoms + compatible physical examination findings + exclusion of other conditions.

Complementary Codes:

Although not mandatory in this case, an additional code could be considered to specify the irritative/allergic nature of vulvitis, if available in the coding system used. For complete documentation, also record the identified contributing factors (moisture exposure, use of irritant product).

Documented Therapeutic Plan:

Guidance on appropriate vulvar hygiene
Discontinuation of irritant products
Cold compresses for symptomatic relief
Low-potency topical corticosteroid
Reevaluation in two weeks

This case exemplifies appropriate application of code GA00, with complete documentation that justifies the choice and allows appropriate audit.

7. Related Codes and Differentiation

Within the Same Category

GA01: Inflammatory disorders of the uterus, except cervix

When to use GA01: This code is appropriate when the inflammatory process affects the uterine body, including endometrium (endometritis) or myometrium (myometritis). Typical manifestations include pelvic pain, uterine tenderness on bimanual palpation, abnormal uterine bleeding, fever, and in severe cases, systemic signs of infection.

Main difference vs. GA00: The fundamental distinction is anatomical. GA01 refers to internal uterine structures, while GA00 involves external genital structures (vulva). Clinically, GA01 presents with deep pelvic symptoms and uterine changes on examination, while GA00 manifests with superficial symptoms and visible changes on the vulva.

GA02: Vaginitis

When to use GA02: Use this code when the inflammatory process is primarily localized to the vagina, characterized by abnormal vaginal discharge (change in quantity, color, consistency, or odor), vaginal pruritus, dyspareunia, and inflammatory signs of the vaginal mucosa on speculum examination.

Main difference vs. GA00: Anatomical location is the key differentiator. GA02 involves the vaginal canal with discharge as the cardinal symptom, while GA00 affects the vulva (external structures) with pruritus and vulvar discomfort as main manifestations. In vulvovaginitis (simultaneous involvement), the code should reflect the predominant site of the process.

GA03: Diseases of Bartholin gland

When to use GA03: Appropriate for specific pathologies of the Bartholin glands, including cysts (painless, fluctuant, unilateral mass in the vestibule), abscesses (painful, erythematous, warm mass with acute inflammatory signs), or bartholinitis (glandular inflammation).

Main difference vs. GA00: GA03 is specific for localized glandular pathology, presenting as a unilateral palpable mass in the posterolateral region of the vaginal vestibule. GA00 represents diffuse or multifocal inflammation of the vulvar surface, without formation of a localized mass or specific glandular involvement.

Differential Diagnoses

Vulvar Lichen Sclerosus: Chronic dermatological condition characterized by whitish plaques, skin atrophy, loss of vulvar architecture, and intense pruritus. Requires specific dermatological code, not GA00.

Genital Herpes: Viral infection presenting with grouped painful vesicles that progress to ulcers. Although it causes vulvar inflammation, it has a specific code for herpetic infection.

Vulvovaginal Candidiasis: Frequently causes secondary vulvitis, but when there is significant vaginal involvement with characteristic discharge, it may require vaginitis code (GA02) as primary.

Contact Dermatitis: Can cause vulvitis, appropriately coded as GA00 when the primary manifestation is vulvar inflammation.

8. Differences with ICD-10

In ICD-10, acute vulvitis was coded as N76.2 and subacute and chronic vulvitis as N76.3. The N76 category of ICD-10 encompassed "Other inflammations of the vagina and vulva," with less specific subdivisions.

Main changes in ICD-11:

ICD-11 brought greater anatomical specificity with the creation of code GA00 exclusively for vulvitis, clearly separating it from other inflammatory conditions of the female genital tract. This separation better reflects clinical practice, where the distinction between vulvitis, vaginitis, and other conditions is fundamental for appropriate management.

The hierarchical structure of ICD-11 is more logical and intuitive, organizing conditions by anatomical location in a clearer manner. The category of "Inflammatory disorders of the female genital tract" groups related codes in a more coherent way.

Practical impact:

For healthcare professionals, the transition requires familiarity with the new code structure, but offers greater diagnostic precision. The increased specificity facilitates epidemiological studies, clinical research, and healthcare quality analyses.

For health information systems, the implementation of ICD-11 requires software updates and team training, but results in more precise and internationally comparable data.

For patients, more precise coding can improve continuity of care, facilitate communication between professionals, and ensure adequate coverage by health systems.

9. Frequently Asked Questions

1. How is vulvitis diagnosed?

The diagnosis of vulvitis is primarily clinical, based on detailed history and careful physical examination. The physician evaluates reported symptoms (pruritus, burning, pain, discomfort), investigates triggering factors, and performs visual inspection of the vulva identifying inflammatory signs such as erythema, edema, and lesions. Complementary tests such as microscopy of secretions, cultures, and rarely biopsy may be necessary to identify the specific cause or exclude other conditions. Careful differential diagnosis is essential to distinguish vulvitis from other vulvar pathologies.

2. Is treatment available in public health systems?

Yes, treatment for vulvitis is generally available in public health systems, as it primarily involves general measures and common medications. Therapeutic options include hygiene guidance, removal of irritating factors, topical medications (corticosteroids, antifungals, antibiotics when indicated), and occasionally systemic medications. Most of these treatments are part of essential medication lists and are accessible in basic health services. Complex or refractory cases may require referral to specialists.

3. How long does treatment last?

The duration of treatment varies according to the cause and severity of vulvitis. Acute cases of irritative or allergic vulvitis may resolve in a few days to two weeks with removal of the causative factor and symptomatic treatment. Infectious vulvitis usually requires seven to 14 days of specific treatment. Chronic or recurrent cases may require prolonged treatment for weeks to months, in addition to continuous preventive measures. Medical follow-up allows therapeutic adjustments according to individual response.

4. Can this code be used in medical certificates?

Yes, the code GA00 can be used in medical certificates when appropriate. Documentation must respect patient privacy, and the decision about the level of detail included in the certificate should consider the context (work leave, justification for school absence, etc.). In many cases, it is possible to provide a certificate without specifying the complete diagnosis, using more generic terms if the patient prefers. Local legislation regarding medical privacy and certificate requirements should always be respected.

5. Is vulvitis a sexually transmitted infection?

Not necessarily. Although some vulvitis cases are caused by infectious agents that can be sexually transmitted (such as certain types of candidiasis, trichomoniasis, or herpes), many vulvitis cases have non-infectious causes, including chemical irritation, allergies, contact dermatitis, trauma, or dermatological conditions. Most vulvitis is not related to sexual activity and can occur in women of any age, including children and non-sexually active women.

6. Can vulvitis affect fertility?

Generally, isolated vulvitis does not directly affect fertility, as it involves only external genital structures. However, if not treated appropriately, vulvitis can ascend causing vaginitis or infections of the upper genital tract, which could potentially impact fertility. Additionally, the discomfort associated with vulvitis may temporarily interfere with sexual activity. Appropriate and timely treatment prevents complications and restores normal reproductive well-being.

7. Is partner treatment necessary?

It depends on the cause of vulvitis. In cases of irritative, allergic vulvitis, or those related to non-infectious factors, partner treatment is not necessary. When vulvitis is caused by sexually transmissible infectious agents (such as trichomoniasis or certain cases of recurrent candidiasis), simultaneous partner treatment may be recommended to prevent reinfection. The physician will evaluate each case individually and provide specific guidance on the need for partner treatment.

8. How to prevent vulvitis recurrence?

Prevention of recurrence involves multiple strategies: maintaining adequate vulvar hygiene with gentle, fragrance-free products, avoiding douching, wearing cotton underwear and non-tight outer clothing, changing wet clothes promptly, avoiding prolonged use of daily pads, maintaining control of predisposing conditions (such as diabetes), avoiding known irritating products, and maintaining regular medical follow-up. In cases of recurrent vulvitis, detailed investigation to identify and correct predisposing factors is fundamental for effective prevention.

Conclusion

The ICD-11 code GA00 for vulvitis represents an essential tool in the precise coding of vulvar inflammatory processes. Proper understanding of when and how to use this code, including differentiation of related conditions and appropriate documentation, is fundamental for health professionals involved in the care of patients with gynecological conditions. The correct application of code GA00 contributes to accurate medical records, reliable epidemiological studies, appropriate reimbursement, and ultimately improvement in the quality of care provided to patients with vulvitis.

External References

This article was prepared based on reliable scientific sources:

References verified on 2026-02-04

Vulvitis

Compartilhar